Valence 標誌
熱門
登入

加入到自選清單
專業圖表

Elutia Inc.

NasdaqCM: ELUT · 即時價格 · USD
0.94
+0.08 (9.30%)
收盤時： Aug 14, 2026, 3:58 PM
0.90
-4.31%
盤前: 7:34 AM

Elutia Inc. (ELUT) Stock Price, Analysis & Data

9.30%
買價0.65
市值41.6M
營收 (ttm)12.14M
淨利（ttm）-22.43M
貝塔n/a
EPS (ttm)-0.53
本益比（ttm）n/a
正向 PE-0.86
P/B (ttm)2.64
P/S (ttm)3.43
Earnings DateNov 12, 2026
賣價1.11
成交量71,125
20 日平均成交量89,075
打開0.88
上一頁關閉0.86
日間範圍0.86 - 0.95
52 週範圍0.50 - 2.50
分析師Strong Buy
目標價5 (431.91%)
股利n/a
Ex-股利日期n/a

關於ELUT

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tis...

[閱讀更多]
工業 Medical Devices
部門 Healthcare
IPO 日期 Oct 8, 2020
員工 25
證券交易所 NasdaqCM
股票代號 ELUT
網站 https://elutia.com
完整的公司簡介

財務表現

Elutia 在 2025 年的營收為 12.29M，較前一年的 14.47M 減少 -15.03%。 淨利為 53.38M，較前期減少 -198.95%。

財務報表

分析師預測

根據1 分析師評等，ELUT股票的平均評等為「Strong Buy」。 12個月股價預測為5，與最新價格相比為上漲空間的431.91%。

股票預測

獲利驚喜

Elutia 已於 Aug 13, 2026 公布季度財報：
  • 營收的 $3.11M 錯過估計 $0, 與 5.52% YoY 成長.
  • EPS 的 -0.17 錯過估計 -0.02, 與 26.09% YoY 成長.

    • 下次財報發布

    Elutia Inc. 定於發布財報 Nov 12, 2026, 在​​市場交易時間內。
    分析師預估營收 ... 升級
    news image

    2 天 前 · Moby

    Elutia Inc. Q2 2026 Earnings Call Summary

    Moby summary of Elutia Inc.'s Q2 2026 earnings call

    news image

    3 天 前 · GuruFocus.com

    Elutia Inc (ELUT) (Q2 2026) Earnings Call Highlights: Strategic Pivot to NXT41X Drives Strong ...

    Elutia Inc (ELUT) reports Q2 2026 results, highlighting robust surgeon interest in NXT41X and a strengthened balance sheet despite a slight revenue dip.

    news image

    3 月 前 · Motley Fool

    Elutia (ELUT) Q1 2026 Earnings Transcript

    Bernadine Cherniak: Thank you, operator, and thank you all for participating in today's call. Earlier today, Elutia released financial results for the first quarter ended March 31, 2026. Before we b...

    news image

    3 月 前 · Moby

    Elutia Inc. Q1 2026 Earnings Call Summary

    Moby summary of Elutia Inc.'s Q1 2026 earnings call

    news image

    3 月 前 · GuruFocus.com

    Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts

    Elutia Inc (ELUT) reports a 6% increase in total net sales and significant progress in its NXT-41 regulatory program, despite challenges in SimpliDerm revenue and increased net loss.

    第 1 頁，共 2 頁